| Literature DB >> 28446424 |
Debbie Matthews1, Louise Bath2, Wolfgang Högler3,4, Avril Mason5, Arlene Smyth6, Mars Skae7,8.
Abstract
Pubertal induction in girls with ovarian insufficiency aims to mimic normal puberty, a highly complex process. Here we amalgamate the sparse global evidence and propose three options for pubertal induction regimens including oral ethinyloestradiol, and oral and transdermal 17β-oestradiol. The introduction of progestogens is discussed and the transition to hormone supplementation for adult women. The merits and disadvantages of the different options are detailed. The available evidence indicates that transdermal 17β-oestradiol has the most favourable efficacy, safety and cost profile but randomised controlled trials are urgently required to determine which regimen provides the best clinical outcomes. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: Oestrogen; Progestogen; Puberty
Mesh:
Substances:
Year: 2017 PMID: 28446424 DOI: 10.1136/archdischild-2016-311372
Source DB: PubMed Journal: Arch Dis Child ISSN: 0003-9888 Impact factor: 3.791